Application 202993
- Type
- ANDA
- Sponsor
- PAR PHARM INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE | DEXTROMETHORPHAN HYDROBROMIDE;QUINIDINE SULFATE | CAPSULE;ORAL | 20MG;10MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dextromethorphan hydrobromide and quinidine sulfate | DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE | Camber Pharmaceuticals, Inc. | 7028dcb7-f436-4cf6-9beb-23c1d215c798 | 2025-02-03 | Warnings, Adverse reactions | Dextromethorphan hydrobromide and quinidine sulfate |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.